Skip to main content
SpringerLink
Log in

Metabolische Chirurgie

Metabolic surgery

  • CME Zertifizierte Fortbildung
  • Published:
Der Chirurg Aims and scope Submit manuscript

Zusammenfassung

Adipositas und Diabetes mellitus Typ 2 (T2DM) nehmen global stark zu. Sie stellen weltweit ein wesentliches Problem der Volksgesundheit und Gesundheitsökonomie dar. Während die Chirurgie inzwischen in der Behandlung der morbiden Adipositas einen festen Stellenwert hat (bariatrische Chirurgie), kommt aktuell der Frage nach einer operativen Therapie eines alleinigen T2DM immer mehr Bedeutung zu (metabolische Chirurgie). Die möglichen operativen Therapieverfahren zeigen dabei eine unterschiedlich starke Beeinflussung des Gewichtes und der assoziierten Begleiterkrankungen. Die genaue Kenntnis der zur Verfügung stehenden operativen Therapien bei morbider Adipositas, deren Risiken und Anforderungen an den minimal-invasiven Chirurgen, deren Effektivität auch in Hinblick auf assoziierte Begleiterkrankungen und, soweit bekannt, deren Wirkmechanismen, sind eine entscheidende Voraussetzung für den gezielten Einsatz.

Abstract

The prevalence of obesity and diabetes mellitus type 2 is constantly rising worldwide and is one of the most threatening global health and health economic problems. Whereas bariatric surgery is well established in the treatment of morbid obesity, the surgical treatment options for type 2 diabetes mellitus alone are still under discussion (metabolic surgery). Bariatric procedures differ considering weight loss and influencing associated comorbidities. Detailed knowledge of available surgical treatment options for morbid obesity, the risks and requirements of laparoscopic skills, effectiveness and, as far as already known, mechanisms of action are crucial for appropriate implementation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5
Abb. 6
Abb. 7

Literatur

  1. Dixon JB, Zimmet P, Alberti KG et al (2011) Bariatric surgery: an IDF statement for obese Type 2 diabetes (1). Diabet Med 28: 628–642

    Article  PubMed  CAS  Google Scholar 

  2. Gregg EW, Cheng YJ, Narayan KM et al (2007) The relative contributions of different levels of overweight and obesity to the increased prevalence of diabetes in the United States: 1976–2004. Prev Med 45:348–352

    Article  PubMed  Google Scholar 

  3. Ariza MA, Vimalananda VG, Rosenzweig JL (2010) The economic consequences of diabetes and cardiovascular disease in the United States. Rev Endocr Metab Disord 11:1–10

    Article  PubMed  Google Scholar 

  4. Buchwald H (2010) Surgery on obese patients. J Am Coll Surg 210:1012–1013

    Article  PubMed  Google Scholar 

  5. Runkel N, Colombo-Benkmann M, Huttl TP et al (2011) Evidence-based German guidelines for surgery for obesity. Int J Colorectal Dis 26:397–404

    Article  PubMed  Google Scholar 

  6. Suter M, Paroz A, Calmes JM et al (2006) European experience with laparoscopic Roux-en-Y gastric bypass in 466 obese patients. Br J Surg 93:726–732

    Article  PubMed  CAS  Google Scholar 

  7. Meneghini LF (2007) Impact of bariatric surgery on type 2 diabetes. Cell Biochem Biophys 48:97–102

    Article  PubMed  CAS  Google Scholar 

  8. Rubino F (2008) Is Type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis. Diabetes Care 31:290–296

    Article  Google Scholar 

  9. Buchwald H, Oien DM (2009) Metabolic/bariatric surgery worldwide 2008. Obes Surg 19:1605–1611

    Article  PubMed  Google Scholar 

  10. Fried M, Ribaric G, Buchwald JN et al (2010) Metabolic surgery for the treatment of type 2 diabetes in patients with BMI < 35 kg/m2: An integrative review of early studies. Obes Surg 20:776–790

    Article  PubMed  CAS  Google Scholar 

  11. Mingrone G, Panunzi S, De Gaetano A et al (2012) Bariatric surgery versus conventional medical therapy for Type 2 diabetes. N Engl J Med (in press)

  12. Schauer PR, Kashyap SR, Wolski K et al (2012) Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med (in press)

  13. Kremen AJ, Linner JH, Nelson CH (1954) An experimental evaluation of the nutritional importance of proximal and distal small intestine. Ann Surg 140:439–448

    Article  PubMed  CAS  Google Scholar 

  14. Buchwald H, Varco RL (1971) A bypass operation for obese hyperlipidemic patients. Surgery 70:62–70

    PubMed  CAS  Google Scholar 

  15. Buchwald H, Buchwald JN (2002) Evolution of operative procedures for the management of morbid obesity 1950–2000. Obes Surg 12:705–717

    Article  PubMed  Google Scholar 

  16. Suter M, Donadini A, Romy S et al (2011) Laparoscopic Roux-en-Y gastric bypass: significant long-term weight loss, improvement of obesity-related comorbidities and quality of life. Ann Surg 254:267–273

    Article  PubMed  Google Scholar 

  17. Higa K, Ho T, Tercero F et al (2011) Laparoscopic Roux-en-Y gastric bypass: 10-year follow-up. Surg Obes Relat Dis 7:516–525

    Article  PubMed  Google Scholar 

  18. Christou NV (2009) Impact of obesity and bariatric surgery on survival. World J Surg 33:2022–2027

    Article  PubMed  Google Scholar 

  19. Sjostrom L, Narbro K, Sjostrom CD et al (2007) Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357:741–752

    Article  PubMed  Google Scholar 

  20. Buchwald H, Estok R, Fahrbach K et al (2009) Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122:248–256

    Article  PubMed  Google Scholar 

  21. Buse JB, Caprio S, Cefalu WT et al (2009) How do we define cure of diabetes? Diabetes Care 32:2133–2135

    Article  PubMed  Google Scholar 

  22. Hall TC, Pellen MG, Sedman PC et al (2010) Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity. Obes Surg 20:1245–1250

    Article  PubMed  Google Scholar 

  23. Hamza N, Abbas MH, Darwish A et al (2011) Predictors of remission of type 2 diabetes mellitus after laparoscopic gastric banding and bypass. Surg Obes Relat Dis 7:691–696

    Article  PubMed  Google Scholar 

  24. Scopinaro N, Gianetta E, Pandolfo N et al (1976) Bilio-pancreatic bypass. Proposal and preliminary experimental study of a new type of operation for the functional surgical treatment of obesity. Minerva Chir 31:560–566

    PubMed  CAS  Google Scholar 

  25. Scopinaro N, Gianetta E, Civalleri D et al (1979) Bilio-pancreatic bypass for obesity: II. Initial experience in man. Br J Surg 66:618–620

    Article  PubMed  CAS  Google Scholar 

  26. Scopinaro N, Gianetta E, Civalleri D et al (1980) Two years of clinical experience with biliopancreatic bypass for obesity. Am J Clin Nutr 33:506–514

    PubMed  CAS  Google Scholar 

  27. Marceau P, Biron S, St Georges R et al (1991) Biliopancreatic diversion with gastrectomy as surgical treatment of morbid obesity. Obes Surg 1:381–387

    Article  PubMed  Google Scholar 

  28. Marceau P, Hould FS, Simard S et al (1998) Biliopancreatic diversion with duodenal switch. World J Surg 22:947–954

    Article  PubMed  CAS  Google Scholar 

  29. Biertho L, Lebel S, Marceau S et al (2011) Perioperative complications in a consecutive series of 1000 duodenal switches. Surg Obes Relat Dis [Epub ahead of print]

  30. Marceau P, Biron S, Hould FS et al (2007) Duodenal switch: long-term results. Obes Surg 17:1421–1430

    Article  PubMed  Google Scholar 

  31. Scopinaro N (2006) Biliopancreatic diversion: mechanisms of action and long-term results. Obes Surg 16:683–689

    Article  PubMed  Google Scholar 

  32. Herron DM (2004) Biliopancreatic diversion with duodenal switch vs. gastric bypass for severe obesity. J Gastrointest Surg 8:406–407

    Article  PubMed  Google Scholar 

  33. Scopinaro N, Adami GF, Papadia FS et al (2011) The effects of biliopancreatic diversion on type 2 diabetes mellitus in patients with mild obesity (BMI 30–35 kg/m2) and simple overweight (BMI 25–30 kg/m2): a prospective controlled study. Obes Surg 21:880–888

    Article  PubMed  Google Scholar 

  34. Scopinaro N, Adami GF, Papadia FS et al (2011) Effects of biliopanceratic diversion on type 2 diabetes in patients with BMI 25–35. Ann Surg 253:699–703

    Article  PubMed  Google Scholar 

  35. Topart P, Becouarn G, Salle A (2011) Five-year follow-up after biliopancreatic diversion with duodenal switch. Surg Obes Relat Dis 7:199–205

    Article  PubMed  Google Scholar 

  36. Cho EY, Kemmet O, Frenken M (2011) Biliopancreatic diversion with duodenal switch in patients with type 2 diabetes mellitus: is the chance of complete remission dependent on therapy and duration of insulin treatment? Obes Facts 4(Suppl 1):18–23

    Article  PubMed  CAS  Google Scholar 

  37. Scopinaro N, Marinari GM, Camerini GB et al (2005) Specific effects of biliopancreatic diversion on the major components of metabolic syndrome: a long-term follow-up study. Diabetes Care 28:2406–2411

    Article  PubMed  Google Scholar 

  38. Scopinaro N (2011) Thirty-five years of biliopancreatic diversion: notes on gastrointestinal physiology to complete the published information useful for a better understanding and clinical use of the operation. Obes Surg. DOI 10.1007/s11695-011-0554-3

  39. Rutledge R (2001) The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg 11:276–280

    Article  PubMed  CAS  Google Scholar 

  40. Lee W-J, Yu P-J, Wang W et al (2005) Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity. Ann Surg 242:20–28

    Article  PubMed  Google Scholar 

  41. Mezhir JJ, Gonen M, Ammori JB et al (2011) Treatment and outcome of patients with gastric remnant cancer after resection for peptic ulcer disease. Ann Surg Oncol 18:670–676

    Article  PubMed  Google Scholar 

  42. Toftgaard C (1989) Gastric cancer after peptic ulcer surgery. A historic prospective cohort investigation. Ann Surg 210:159–164

    Article  PubMed  CAS  Google Scholar 

  43. Viste A, Bjornestad E, Opheim P et al (1986) Risk of carcinoma following gastric operations for benign disease. A historical cohort study of 3470 patients. Lancet 2:502–505

    Article  PubMed  CAS  Google Scholar 

  44. Franco JV, Ruiz PA, Palermo M et al (2011) A review of studies comparing three laparoscopic procedures in bariatric surgery: sleeve gastrectomy, Roux-en-Y gastric bypass and adjustable gastric banding. Obes Surg 21:1458–1468

    Article  PubMed  Google Scholar 

  45. Karamanakos SN, Vagenas K, Kalfarentzos F et al (2008) Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg 247:401–407

    Article  PubMed  Google Scholar 

  46. Peterli R, Wolnerhanssen B, Peters T et al (2009) Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. Ann Surg 250:234–241

    Article  PubMed  Google Scholar 

  47. Weiner RA, Weiner S, Pomhoff I et al (2007) Laparoscopic sleeve gastrectomy–influence of sleeve size and resected gastric volume. Obes Surg 17:1297–1305

    Article  PubMed  Google Scholar 

  48. Fischer LJ, Jacobsen G, Wong B et al (2009) NOTES laparoscopic-assisted transvaginal sleeve gastrectomy in humans–description of preliminary experience in the United States. Surg Obes Relat Dis 5:633–636

    Article  PubMed  Google Scholar 

  49. Saber AA, Elgamal MH, Itawi EA et al (2008) Single incision laparoscopic sleeve gastrectomy (SILS): a novel technique. Obes Surg 18:1338–1342

    Article  PubMed  Google Scholar 

  50. Peterli R, Steinert RE, Woelnerhanssen B et al (2012) Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and Sleeve Gastrectomy: a randomized, prospective trial. Obes Surg (in press)

  51. Himpens J, Dobbeleir J, Peeters G (2010) Long-term results of laparoscopic sleeve gastrectomy for obesity. Ann Surg 252:319–324

    Article  PubMed  Google Scholar 

  52. Basso N, Casella G, Rizzello M et al (2011) Laparoscopic sleeve gastrectomy as first stage or definitive intent in 300 consecutive cases. Surg Endosc 25:444–449

    Article  PubMed  CAS  Google Scholar 

  53. Jacobs M, Bisland W, Gomez E et al (2010) Laparoscopic sleeve gastrectomy: a retrospective review of 1- and 2-year results. Surg Endosc 24:781–785

    Article  PubMed  Google Scholar 

  54. Shah PS, Todkar JS, Shah SS (2010) Effectiveness of laparoscopic sleeve gastrectomy on glycemic control in obese Indians with type 2 diabetes mellitus. Surg Obes Relat Dis 6:138–141

    Article  PubMed  Google Scholar 

  55. Vidal J, Ibarzabal A, Nicolau J et al (2007) Short-term effects of sleeve gastrectomy on type 2 diabetes mellitus in severely obese subjects. Obes Surg 17:1069–1074

    Article  PubMed  CAS  Google Scholar 

  56. Lee WJ, Chong K, Ser KH et al (2011) Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg 146:143–148

    Article  PubMed  Google Scholar 

  57. Kunath U, Memari B (1995) Laparoscopic gastric banding for treatment of pathologic obesity. Chirurg 66:1263–1267

    PubMed  CAS  Google Scholar 

  58. Romy S, Donadini A, Giusti V et al (2012) Roux-en-Y gastric bypass vs gastric banding for morbid obesity: A case-matched study of 442 patients. Arch Surg (in press)

  59. Wolnerhanssen BK, Peters T, Kern B et al (2008) Predictors of outcome in treatment of morbid obesity by laparoscopic adjustable gastric banding: results of a prospective study of 380 patients. Surg Obes Relat Dis 4:500–506

    Article  PubMed  Google Scholar 

  60. Stroh C, Hohmann U, Schramm H et al (2011) Fourteen-year long-term results after gastric banding. J Obes 2011:128451

    PubMed  Google Scholar 

  61. Van Nieuwenhove Y, Ceelen W, Stockman A et al (2011) Long-term results of a prospective study on laparoscopic adjustable gastric banding for morbid obesity. Obes Surg 21:582–587

    Article  Google Scholar 

  62. Dixon JB, Murphy DK, Segel JE et al (2012) Impact of laparoscopic adjustable gastric banding on type 2 diabetes. Obes Rev 13:57–67

    Article  PubMed  CAS  Google Scholar 

  63. Sjostrom L, Lindroos AK, Peltonen M et al (2004) Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351:2683–2693

    Article  PubMed  Google Scholar 

  64. Bult MJF, Van Dalen T, Muller AF (2008) Surgical treatment of obesity. Eur J Endocrinol 158:135–145

    Article  PubMed  CAS  Google Scholar 

  65. Sjostrom L, Peltonen M, Jacobson P et al (2012) Bariatric surgery and long-term cardiovascular events. JAMA 307:56–65

    Article  PubMed  Google Scholar 

  66. Bueter M, Laurenius A, Lutz TA et al (2011) Untersuchungen zur Rolle der mechanischen Restriktion nach Magenbypass-Operation. Deutsche Gesellschaft für Chirurgie, Tagungskongress, München 3. bis 6. Mai 2011

  67. Stefater MA, Perez-Tilve D, Chambers AP et al (2010) Sleeve gastrectomy induces loss of weight and fat mass in obese rats, but does not affect leptin sensitivity. Gastroenterology 138:2426–2436

    Article  PubMed  CAS  Google Scholar 

  68. Madan AK, Tichansky DS, Phillips JC (2007) Does pouch size matter? Obes Surg 17:317–320

    Article  PubMed  Google Scholar 

  69. Ashrafian H, Athanasiou T, Li JV et al (2011) Diabetes resolution and hyperinsulinaemia after metabolic Roux-en-Y gastric bypass. Obes Rev 12:257–272

    Article  Google Scholar 

  70. Ashrafian H, Le Roux CW (2009) Metabolic surgery and gut hormones – a review of bariatric entero-humoral modulation. Physiol Behav 97:620–631

    Article  PubMed  CAS  Google Scholar 

  71. Bueter M, Le Roux CW (2011) Gastrointestinal hormones, energy balance and bariatric surgery. Int J Obes (Lond) 35(Suppl 3):35–39

    Google Scholar 

  72. Bueter M, Seyfried F, Germer CT (2010) Why patients lose weight after bariatric operations. Zentralbl Chir 135:28–33

    Article  PubMed  CAS  Google Scholar 

  73. Bueter M, Ashrafian H, Le Roux CW (2009) Mechanisms of weight loss after gastric bypass and gastric banding. Obes Facts 2:325–331

    Article  PubMed  Google Scholar 

  74. Le Roux CW, Bueter M, Theis N et al (2011) Gastric bypass reduces fat intake and preference. Am J Physiol Regul Integr Comp Physiol 301:R1057–1066

    Article  Google Scholar 

  75. Richardson BE, Vander Woude EA, Sudan R et al (2004) Altered olfactory acuity in the morbidly obese. Obes Surg 14:967–969

    Article  PubMed  Google Scholar 

  76. Li JV, Ashrafian H, Bueter M et al (2011) Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. Gut 60:1214–1223

    Article  PubMed  CAS  Google Scholar 

  77. Clément K (2011) Bariatric surgery, adipose tissue and gut microbiota. Int J Obes 35:S7–S15

    Article  Google Scholar 

  78. Li JV, Ashrafian H, Bueter M et al. (2011) Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. Gut 60:1214–1223

    Article  PubMed  CAS  Google Scholar 

  79. Bueter M, Lowenstein C, Ashrafian H et al (2010) Vagal sparing surgical technique but not stoma size affects body weight loss in rodent model of gastric bypass. Obes Surg 20:616–622

    Article  PubMed  Google Scholar 

  80. Sundbom M, Holdstock C, Engstrom BE et al (2007) Early changes in ghrelin following Roux-en-Y gastric bypass: influence of vagal nerve functionality? Obes Surg 17:304–310

    Article  PubMed  Google Scholar 

  81. Friedman MN, Sancetta AJ, Magovern GJ (1955) The amelioration of diabetes mellitus following subtotal gastrectomy. Surg Gynecol Obstet 100:201–204

    PubMed  CAS  Google Scholar 

  82. Lee WJ, Chong K, Chen CY et al (2011) Diabetes remission and insulin secretion after gastric bypass in patients with body mass index < 35 kg/m2. Obes Surg 21:889–895

    Article  PubMed  Google Scholar 

  83. Lee WJ, Wang W, Lee YC et al (2008) Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI> 35 and < 35 kg/m2. J Gastrointest Surg 12:945–952

    Article  PubMed  Google Scholar 

  84. Cohen R, Pinheiro JS, Correa JL et al (2006) Laparoscopic Roux-en-Y gastric bypass for BMI (35 kg/m2): a tailored approach. Surg Obes Relat Dis 2:401–404

    Article  PubMed  Google Scholar 

  85. Tinoco A, El-Kadre L, Aquiar L et al (2011) Short-term and mid-term control of type 2 diabetes mellitus by laparoscopic sleeve gastrectomy with ileal interposition. World J Surg 35:2238–2244

    Article  PubMed  Google Scholar 

  86. Kumar KV, Ugale S, Gupta N et al (2009) Ileal interposition with sleeve gastrectomy for control of type 2 diabetes. Diabetes Technol Ther 11:785–789

    Article  PubMed  Google Scholar 

  87. De Paula AL, Macedo AL, Mota BR et al (2009) Laparoscopic ileal interposition associated to a diverted sleeve gastrectomy is an effective operation for the treatment of type 2 diabetes mellitus patients with BMI 21–29. Surg Endosc 23:1313–1320

    Article  Google Scholar 

  88. Klein S, Fabbrini E, Patterson BW et al (2012) Moderate effect of duodenal-jejunal bypass surgery on glucose homeostasis in patients with type 2 diabetes. Obesity (in press)

  89. Geloneze B, Geloneze SR, Fiori C et al (2009) Surgery for nonobese type 2 diabetic patients: an interventional study with duodenal-jejunal exclusion. Obes Surg 19:1077–1083

    Article  PubMed  Google Scholar 

  90. Kindel TL, Yoder SM, Seeley RJ et al (2009) Duodenal-jejunal exclusion improves glucose tolerance in the diabetic, Goto-Kakizaki rat by a GLP-1 receptor-mediated mechanism. J Gastrointest Surg 13:1762–1772

    Article  PubMed  Google Scholar 

  91. Rubino F, Marescaux J (2004) Effect of duodenal jejunal exclusion in a non-obese animal model of type 2 diabetes. Ann Surg 239:1–11

    Article  PubMed  Google Scholar 

  92. Culnan DM, Albaugh V, Sun M et al (2010) Ileal interposition improves glucose tolerance and insulin sensitivity in the obese Zucker rat. Am J Physiol Gastrointest Liver Physiol 299:G751–760

    Article  PubMed  CAS  Google Scholar 

  93. Cummings BP, Strader AD, Stanhope KL et al (2010) Ileal interposition surgery improves glucose and lipid metabolism and delays diabetes onset in the UCD-T2DM rat. Gastroenterology 138:2437–2446

    Article  PubMed  CAS  Google Scholar 

  94. Wang TT, Hu SY, Gao HD et al (2008) Ileal transposition controls diabetes as well as modified duodenal jejunal bypass with better lipid lowering in a nonobese rat model of type II diabetes by increasing GLP-1. Ann Surg 247:968–975

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt für sich und seine Koautoren an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie, Universitätsklinikum Würzburg, Zentrum für operative Medizin (ZOM), Oberdürrbacherstr. 6, 97080, Würzburg, Deutschland

    C. Jurowich, C.T. Germer, F. Seyfried & A. Thalheimer

Authors
  1. C. Jurowich
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C.T. Germer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. Seyfried
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Thalheimer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Jurowich.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jurowich, C., Germer, C., Seyfried, F. et al. Metabolische Chirurgie. Chirurg 83, 583–600 (2012). https://doi.org/10.1007/s00104-011-2239-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00104-011-2239-9

Schlüsselwörter

Keywords

Search

Navigation